-+ 0.00%
-+ 0.00%
-+ 0.00%
Organon says FDA accepts Miudella IUD sNDA for 6-year use review
Share
Listen to the news
Organon says FDA accepts Miudella IUD sNDA for 6-year use review
  • FDA accepted for review an sNDA seeking to extend MIUDELLA copper IUD use to 6 years.
  • PDUFA action date expected in Q2 2027.
  • Organon licensed global rights from Sebela Women’s Health in June 2026; US commercial launch expected in late 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260914839018) on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending